J&J Faces New Round Of Risperdal Suits With Ghostwriting Claims
Executive Summary
Johnson & Johnson has been hit with another wave of Risperdal (risperidone) product liability suits. While previous suits have claimed the antipsychotic caused diabetes, the current batch alleges that the drug induced gynecomastia, or breast enlargement, in boys and young men